Disruption of PPARγ signaling can lead to altered expression of genes involved in lipid metabolism, such as fatty acid binding protein 4 (FABP4) and CD36, contributing to the development of a pro-inflammatory state and endothelial dysfunction. The gene discussed is PPARG; the disease is endothelial dysfunction.